Risk factors for HIV seroconversion in a prospective study of zidovudine (ZDV) post-exposure prophylaxis (PEP).

被引：0
|
作者：
Beekmann, SE
Fahrner, R
Gerberding, JL
Koziol, D
Henderson, DK
机构：
[1] NIH,CTR CLIN,BETHESDA,MD 20892
[2] SAN FRANCISCO GEN HOSP,SAN FRANCISCO,CA 94110
[3] UNIV IOWA,COLL MED,IOWA CITY,IA 52242
来源：
CLINICAL INFECTIOUS DISEASES | 1996年 / 23卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers
    Kennedy, I
    Williams, S
    OCCUPATIONAL MEDICINE-OXFORD, 2000, 50 (06): : 387 - 391
  • [42] Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men
    Valera, Pamela
    Ali, Zaire S.
    Cunningham, Diamond
    McLaughlin, Christopher
    Acevedo, Sebastian
    AMERICAN JOURNAL OF MENS HEALTH, 2022, 16 (04)
  • [43] PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis
    Faetkenheuer, G.
    Jessen, H.
    Stoehr, A.
    Jung, N.
    Jessen, A. B.
    Kuemmerle, T.
    Berger, M.
    Bogner, J. R.
    Spinner, C. D.
    Stephan, C.
    Degen, O.
    Vogelmann, R.
    Spornraft-Ragaller, P.
    Schnaitmann, E.
    Jensen, B.
    Ulmer, A.
    Kittner, J. M.
    Haerter, G.
    Malfertheiner, P.
    Rockstroh, J.
    Knecht, G.
    Scholten, S.
    Harrer, T.
    Kern, W. V.
    Salzberger, B.
    Schuermann, D.
    Ranneberg, B.
    HIV MEDICINE, 2016, 17 (06) : 453 - 459
  • [44] Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study
    Chauveau, Marie
    Billaud, Eric
    Bonnet, Benedicte
    Merrien, Dominique
    Hitoto, Hikombo
    Bouchez, Sabelline
    Michau, Christophe
    Hall, Nolwenn
    Perez, Lucia
    Secher, Solene
    Raffi, Francois
    Allavena, Clotilde
    Bernaud, Camille
    Brunet, Cecile
    Morineau-Le Houssine, Pascale
    Reliquet, Veronique
    Vivrel, Florian
    Hue, Herve
    Cavellec, Morane
    Soria, Albane
    Blanchi, Sophie
    Crochette, Nicolas
    Hitoto, Hikombo
    Perez, Lucia
    Qatib, Naoual
    Stragier, Olivier Bollengier
    Esnault, Jean-Luc
    Guimard, Thomas
    Morrier, Marine
    Perre, Philippe
    Laine, Laetitia
    Grand-Courault, Carole
    Jovelin, Thomas
    Secher, Solene
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (04) : 1021 - 1027
  • [45] HIV post-exposure prophylaxis (PEP)-the perspective of the A&E department at a Tertiary Referral Centre with a specialized HIV centre
    Schlabe, Stefan
    Boesecke, Christoph
    Schwarze-Zander, Carolynne
    Van Bremen, Kathrin
    Graeff, Ingo
    Christof, Burger
    Wasmuth, Jan-Christian
    Rockstroh, Juergen K.
    INFECTION, 2021, 49 (SUPPL 1) : S47 - S47
  • [46] Risk of HIV transmission from patients to surgeons in the era of post-exposure prophylaxis
    Goldberg, D
    Johnston, J
    Cameron, S
    Fletcher, C
    Stewart, M
    McMenamin, J
    Codere, G
    Hutchinson, S
    Raeside, F
    JOURNAL OF HOSPITAL INFECTION, 2000, 44 (02) : 99 - 105
  • [47] HIV prevention with post-exposure prophylaxis-in-pocket
    Heendeniya, Amila
    Bogoch, Isaac I.
    LANCET PUBLIC HEALTH, 2019, 4 (10): : E494 - E494
  • [48] HIV post-exposure prophylaxis after sexual assault
    Crossley, J
    EMERGENCY MEDICINE JOURNAL, 2004, 21 (04) : 403 - 403
  • [49] HIV post-exposure prophylaxis `safe', nevirapine excepted
    Reactions Weekly, 2003, 975 (1) : 5 - 5
  • [50] HIV post-exposure prophylaxis compliance in a tertiary hospital
    Villamarin Vallejo, L.
    Pages-Puigdemont, N.
    Aliberas-Moragas, J.
    Masip Torne, M.
    Mateo Garcia, G.
    Gutierrez Macia, M.
    Sambeat Domenech, M. A.
    Mangues Bafalluy, M. A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 932 - 932
12345